Table 3 Postoperative analgesic consumption and incidence of postoperative adverse effects
Postoperative analgesic consumption | GA (n = 26) | RA (n = 26) | P values |
|---|---|---|---|
Morphine (mg) | |||
 Morphine consumption in the PACU | 2.3 (0–3) | 0 (0–0) | < 0.001* |
Oral Dihydrocodeine (mg) consumption | |||
 Postoperative 2 h | 0 (0–0) | 0 (0–0) | 1.000 |
 Postoperative 24 h | 0 (0–0) | 0 (0–0) | 0.149 |
 Postoperative 48 h | 0 (0–0) | 0 (0–0) | 0.719 |
Postoperative adverse effects | |||
 Emergence agitation (Aono’s four-point scale) in the PACU | 1 (1–1) | 1 (1–1) | 0.057 |
 Nausea | 30.7% (13,49) | 0.0% (NA) | 0.004* |
 Vomiting | 19.2% (4,34) | 0.0% (NA) | 0.050* |
 Dizziness | 30.7% (13,49) | 7.6% (−2,18) | 0.075 |
 Pruritus | 0.0% (NA) | 0.0% (NA) | 1.000 |
 Wound infection | 0.0% (NA) | 0.0% (NA) | 1.000 |
 Urinary retention | 0.0% (NA) | 3.8% (−4,12) | 1.000 |
 Others | 11.5% (−1,25) | 0.0% (NA) | 0.235 |
Symptoms of the operated upper limb | |||
 Paresthesia | 23.1% (7,39) | 11.5% (−1,25) | 0.465 |
 Tingling | 23.1% (7,39) | 7.7% (−2,18) | 0.248 |
 Abnormal sensation | 19.2% (4,34) | 3.8% (−4,12) | 0.191 |
 Weakness | 30.8% (13,49) | 7.7% (−2,18) | 0.035* |
 Others | 11.5% (−1,25) | 0.0% (NA) | 0.235 |